Pathologic characteristics of drug-induced lung disease

Clinics in Chest Medicine

Volumn 25, Issue 1, 2004, Pages 37-45

  Flieder, Douglas B ^a   Travis, William D ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CAPTOPRIL; CEPHALOSPORIN; COCAINE; COTRIMOXAZOLE; CYANOCOBALAMIN; DIPYRIDAMOLE; ENALAPRIL; HYDROCORTISONE; INTERLEUKIN 2; IRON DEXTRAN; KETAMINE; METHOTREXATE; METHYLDOPA; METOPROLOL; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PHYTOMENADIONE; PINDOLOL; PROPRANOLOL; PROTAMINE; TARTRAZINE; UNINDEXED DRUG;

AIRWAY OBSTRUCTION; ALLERGIC PNEUMONITIS; BRONCHOSPASM; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAPHRAGM PARALYSIS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; EMPHYSEMA; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; LOEFFLER PNEUMONIA; LUNG ALVEOLUS HYPOVENTILATION; LUNG ALVEOLUS PROTEINOSIS; LUNG CALCIFICATION; LUNG DISEASE; LUNG EDEMA; LUNG EMBOLISM; LUNG GRANULOMATOSIS; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG SURGERY; LUNG VEIN OBSTRUCTION; PATHOPHYSIOLOGY; PLEURA DISEASE; PRIORITY JOURNAL; PULMONARY ARTERY DISEASE; PULMONARY HYPERTENSION; PULMONARY VEIN OBSTRUCTION; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSBRONCHIAL BIOPSY; VASCULAR DISEASE; VASCULITIS;

BIOPSY; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILIA; HUMANS; LUNG; LUNG DISEASES; PLEURAL DISEASES; PULMONARY ALVEOLI; PULMONARY EDEMA;

EID: 1542302727     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(03)00138-2     Document Type: Review

References (34)

1. Rosenow III EC. Drug-induced pulmonary disease. Dis Mon 1994;40:253-310.
2. Irey NS. Tissue reactions to drugs. Am J Pathol 1976;82:613-47.
3. Lemesnse GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med 1994;150:258-60.
4. O'Donnell AE, Selig J, Aravamuthan M, et al. Pulmonary complications associated with illicit drug use. An update. Chest 1995;108:460-3.
5. Rosenow EC, Myers JL, Swensen SJ, et al. Drug-induced pulmonary disease: an update. Chest 1992;102:239-50.
6. Coudert B, Baily F, Lombard JN, et al. Amiodarone pneumonitis: bronchoalveolar lavage findings in 15 patients and review of the literature. Chest 1992;102:1005-12.
7. Cooper Jr JA, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: cytotoxic drugs. Am Rev Resp Dis 1986;133:321-40.
8. Akoun GM, Gauthier-Rahman S, Milleron BJ, et al. Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism. Chest 1984;85:133-5.
9. Zitnik RJ, Cooper Jr JA. Drug-induced pulmonary disease. Clin Chest Med 1990;11:139-50.
10. Van Mieghem W, Coolen L, Malysse I, et al. Amiodarone and the development of ARDS after lung surgery. Chest 1994;105:1642-5.
11. O'Driscoll BR, Hasleton PS, Taylor PM, et al. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990;323:378-82.
12. Akoun GM, Cadranel JL, Rosenow III EC, et al. Bronchoalveolar lavage cell data in drug-induced pneumonitis. Allerg Immunol (Paris) 1991;23:245-52.
13. White DA, Rankin JA, Stover DE, et al. Methotrexate pneumonitis: bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989;139:18-21.
14. Akoun GM, Cadranel JL, Milleron BJ, et al. Bronchoalveolar lavage cell data in 19 patients with drug-associated pneumonitis (except amiodarone). Chest 1991;99:98-104.
15. Garcia JG, Munim A, Nugent KM, et al. Alveolar macrophage gold retention in rheumatoid arthritis. J Rheumatol 1987;14:435-8.
16. Martin II WJ. Drug-induced lung disease. In: Baughman RP, editor. Bronchoalveolar lavage. St Louis (MO): Mosby Year Book; 1992. p. 193-211.
17. Ohar JA, Jackson F, Dettenmeier PA, et al. Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis. Chest 1992;102:999-1004.
18. Vijeyaratnam GS, Corrin B. Fine structural alterations in the lungs of iprindole-treated rats. J Pathol 1974;114:233-9.
19. Heath D, Smith P, Hasleton PS. Effects of chlorphentermine on the rat lung. Thorax 1973;28:551-8.
20. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
21. Myers JL. Pathology of drug-induced lung disease. In: Katzenstein A, editor. Katzenstein and Askin's surgical pathology of non-neoplastic disease. 3rd edition. Philadelphia: WB Saunders; 1997. p. 81-111.
22. Fraser RS, Müller NL, Colman N, et al. Drugs. In: Fraser RS, Colman N, Müller NL, Paré PD, editor. Fraser and Paré's diagnosis of diseases of the chest. Philadelphia: WB Saunders; 1999. p. 2537-83.
23. Travis WD, Colby TV, Koss MN, et al. Drug and radiation reactions. In: King DW, editor. Non-neoplastic disorders of the lower respiratory tract. 1st edition. Washington, DC.: American Registry of Pathology and the Armed Forces Institute of Pathology; 2002. p. 321-50.
24. Ameisen JC, Capron A, Joseph M, et al. Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks; diagnostic and physiopathologic implications. Int Arch Allergy Appl Immunol 1985;78:438-48.
25. Allen JN, Pacht ER, Gadek JE, et al. Acute eosinophilic pneumonia as a reversible cause of non-infectious respiratory failure. N Engl J Med 1989;321:569-74.
26. Colby TV, Fukuoka J, Ewaskow SP, et al. Pathologic approach to pulmonary hemorrhage. Ann Diagn Pathol 2001;5:309-19.
27. Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemost 1999;25:217-21.
28. Gagnadoux F, Capron F, Lebeau B. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. Lung Cancer 2002;36:213-5.
29. Gupta RC, Lavengood Jr R, Smith JP. Miliary tuberculosis due to intravesical bacillus Calmette-Guerin therapy. Chest 1988;94:1296-8.
30. Bedorssian CWM, Luna MA, Conklin RH, et al. Alveolar proteinosis as a consequence of immunosuppression: a hypothesis based on clinical and pathologic observations. Hum Pathol 1980;11:527-35.
31. Durant JR, Norgard MJ, Murad TM, et al. Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU). Ann Intern Med 1979;90:191-4.
32. Doll DC. Fatal pneumothorax associated with bleomycin-induced pulmonary fibrosis. Cancer Chemother Pharmacol 1986;17:294-5.
33. Hsu JR, Chang SC, Perng RP. Pneumothorax following cytotoxic chemotherapy in malignant lymphoma. Chest 1990;98:1512-3.
34. Morelock SY, Sahn SA. Drugs and the pleura. Chest 1999;116:212-21.